The Current Ratio of NeuBase Therapeutics Inc (NBSE) is 8.36.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2022-12-31 | 8.36 |
| 2022-09-30 | 5.91 |
| 2021-09-30 | 13.11 |
| 2020-09-30 | 10.42 |
| 2019-09-30 | 4.41 |
| 2018-09-30 | 5.48 |
| 2017-09-30 | 2.64 |
| 2016-09-30 | 2.97 |
| 2015-09-30 | 7.48 |
| 2014-09-30 | 2.53 |